Tuberculosis and multidrug-resistant tuberculosis : epidemiology, diagnosis, resistance mechanisms, treatment strategies and novel drugs [E-Book]
Series: Allergies and infectious diseasesPublisher: [Hauppauge] New York : Nova Biomedical, [2013]Description: 1 online resourceContent type:- text
- computer
- online resource
- 9781628083392
- 1628083395
Item type | Home library | Class number | URL | Status | Date due | Barcode | |
---|---|---|---|---|---|---|---|
Electronic book | Stenhouse Library | Link to resource | Available |
Includes bibliographical references (pages 79-128) and index.
Description based on print version record.
TUBERCULOSIS AND MULTIDRUG-RESISTANT TUBERCULOSIS ; TUBERCULOSIS AND MULTIDRUG-RESISTANT TUBERCULOSIS ; Library of Congress Cataloging-in-Publication Data ; Contents; Preface ; Chapter I Natural History of Tuberculosis ; Chapter II Global Epidemiology of TB, Drug-Resistant TB, MDR-TB and XDR-TB ; Chapter III Chemotherapy for TB and Evolution of Drug-Resistant TB ; Chapter IV Anti-TB Drugs: ChMechanism of Action and Molecular Basis of Resistance ; Chapter V Diagnosis of Active TB Disease ; Chapter VI Diagnosis of Drug-Resistant TB, MDR-TB and XDR-TB.
6A. Conventional Diagnosis of Drug-Resistant TB, MDR-TB and XDR-TB 6B. Molecular Diagnosis of Drug-Resistant TB, MDR-TB and XDR-TB ; Chapter VII Treatment of Drug-Resistant TB, MDR-TB and XDR-TB ; 7A. Treatment of Drug-Resistant TB, MDR-TB and XDR-TB in HIV-Seronegative Adults ; 7B. Treatment of Drug-Resistant TB in Children ; 7C. Treatment of Drug-Resistant TB in HIV-Coinfected Patients ; Chapter VIII New Drugs for the Treatment of TB and Drug-Resistant TB ; 8A. Clinical Re-evaluation of Existing Drugs ; 8B. New Anti-TB Drugs Under Development ; 8B.1. New Drugs under Clinical Evaluation.
8B.2. New Drugs in Preclinical Development 8B.3. Promising Lead Compounds as Anti-TB Drugs; Chapter IX Concluding Remarks ; References; Index.
Master record variable field(s) change: 050, 082, 650
There are no comments on this title.